Preservation of the bystander cytocidal effect of irradiated herpes simplex virus thymidine kinase (HSV-tk) modified tumor cells

Journal of Neuro-Oncology

Volumn 30, Issue 3, 1996, Pages 225-236

  Vrionis, Fotios D ^a   Wu, Julian K ^a,b   Qi, Peimin ^a   Cano, William G ^a   Cherington, Van ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Brain tumor; Bystander effect; Carcinomatous meningitis; Gene therapy; Irradiation; Thymidine kinase

Indexed keywords

GANCICLOVIR; THYMIDINE KINASE; VIRUS ENZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TUMOR; CANCER TRANSPLANTATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; GAMMA IRRADIATION; GENE THERAPY; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NONHUMAN; RAT; TUMOR CELL; WALKER CARCINOMA;

EID: 0029973565     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00177273     Document Type: Article

References (27)

1. Caruso M, Panis Y, Gagandeep S, Houssin D, Salzmann J, Klatzmann D: Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci USA 90: 7024-7028, 1993
2. Culver K, Ram Z, Wallbridge S, Hiroyuki I, Oldfield E, Blaese R: In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256: 1550-1552, 1992
3. Freeman S, Abboud C, Whartenby K, Packman C, Koeplin D, Moolten F, Abraham G: The 'bystander effect': tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 53: 5274-5283, 1993
4. Moolten F: Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: Paradigm for prospective cancer control strategy. Cancer Res 46: 5276-5281, 1986
5. Oldfield E, Ram Z, Culver K, Blaese R, DeVroom H, Anderson W: Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther 4: 39-69, 1993
6. Ram Z, Culver K, Walbridge S, Blease R, Oldfield E: In situ retroviral-mediated gene transfer for the treatment of brain tumors in rats. Cancer Res 53: 83-88, 1993
7. Takamiya Y, Short M, Moolten F, Fleet C, Mineta T, Break-field X, Martuza R: An experimental model of retrovirus gene therapy for malignant brain tumors. J Neurosurg 79: 104-110, 1993
8. Vrionis F, Wu J, Qi P, Cano W, Cherington V: Tumor cells expressing the herpes simplex virus thymidine kinase gene in the treatment of Walker 256 meningeal neoplasia in rats. J Neurosurg 84: 250-257, 1996
9. Vrionis F, Wu J, Qi P, Cano W, Cherington V: Tumor cells expressing the herpes simplex virus thymidine kinase gene elicit a more potent bystander cytocidal effect than fibroblast virus producer cells in vitro. J Neurosurg 83: 698-704, 1995
10. Wu J, Cano W, Meylaerts S, Qi P, Vrionis F, Cherington V: Bystander tumoricidal effect in the treatment of experimental brain tumors. Neurosurgery 35: 1094-1103, 1994
11. Golumbek P, Hamzeh F, Jaffee E, Levitsky H, Lietman P, Pardoll D: Herpes simplex-1 virus thymidine kinase gene is unable to completely eliminate live, nonimmunogenic tumor cell vaccines. J Immunother 12: 224-230, 1992
12. Osaki T, Tanio Y, Tachibana I, Hosoe S, Kumagai T, Kawase I, Oikawa S, Kishimoto T: Gene therapy for carcinoembryonic antigen-producing human lung cancer cells by cell type-specific expression of herpes simplex virus thymidine kinase gene. Cancer Res 54: 5258-5261, 1994
13. Kooistra KL, Rodriguez M, Powis G, Yaksh TL, Harty GJ, Hilton JF, Laws ER: Development of experimental models for meningeal neoplasia using intrathecal injection of 9L gliosarcoma and Walker 256 carcinosarcoma in the rat. Cancer Res 46: 317-323, 1986
14. Cepko C: Retroviral infection of cells in vitro and in vivo. In: Ausubel F, Brent R, Kingston R, Moore D, Seidman J, Smith J, Struhl K (eds) Current protocols in molecular biology. Greene publishing associates, New York, 1992, pp 9.14.1-9.14.3
15. Hall E: Cell-Survival Curves. In: Hall E (ed) Radiobiology for the Radiologist. J.B. Lippincott, Philadelphia, 1988, pp 17-39
16. Albright N: Computer program for the analysis of cellular survival data. Radiation Res 112: 331-340, 1987
17. Liu Q-Y, Summers W: Site-directed mutagenesis of a nucleotide-binding domain in HSV-1 thymidine Kinase: effects on catalytic activity. Virology 163: 638-642, 1988
18. Martuza R, Malick A, Markert J, Ruffner K, Coen D: Experimental therapy of human glioma by means of a genetically engineered virus mutant. Science 252: 854-856, 1991
19. Boviatsis E, Park J, Sena-Esteves M, Kramm C, Chase M, Efird J, Wei M, Breakefield X, Chiocca E: Long-term survival of rats harboring brain neoplasms treated with ganciclovir and a herpes simplex virus vector that retains an intact thymidine kinase gene. Cancer Res 54: 5745-5751, 1994
20. Ram Z, Walbridge S, Oshiro E, Viola J, Chiang Y, Mueller S, Blaese R, Oldfield E: Intrathecal gene therapy for malignant leptomeningeal neoplasia. Cancer Res 54: 2141-2145, 1994
21. Giangaspero F, Burger P: Correlations between cytologic composition and biologic behavior in the glioblastoma multiform. A postmortem study of 50 cases. Cancer 52: 2320-2333, 1983
22. Bi W, Parysek L, Warnick R, Stambrook P: In vitro evidence that metabolic cooperation is responsible for the bystander effect observed with HSV tk retroviral gene therapy. Hum Gene Ther 4: 725-731, 1993
23. Barba D, Hardin J, Sadelain M, Gage F: Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors. Proc Natl Acad Sci USA 91: 4348-4352, 1994
24. Tapscott S, Miller A, Olson J, Berger M, Groudine M, Spence A: Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection. Proc Natl Acad Sci USA 1994
25. Gansbacher B, Zier K, Cronin K, Hantzopoulos P, Bouchard B, Houghton A, Gilboa E, Golde D: Retroviral gene transfer induced constitutive expression of interleukin-2 or interferon-gamma in irradiated human melanoma cells. Blood 80: 2817-2825, 1992
26. Gastl G, Finstad C, Guarini A, Bosl G, Gilboa E, Bander N, Gansbacher B: Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells. Cancer Res 52: 6229-6236, 1992
27. Al-Nabulsi I, Takamiya Y, Voloshin Y, Dritschilo A, Martuza R, Jorgensen T: Expression of thymidine kinase is essential to low dose radiation resistance of rat glioma cells. Cancer Res 54: 5614-5617, 1994